Bacteremia due to Acinetobacter species other than Acinetobacter baumannii
- PMID: 7698833
- DOI: 10.1007/BF01715492
Bacteremia due to Acinetobacter species other than Acinetobacter baumannii
Abstract
The objective of this study was to describe the clinical features, possible predisposing factors and treatment outcomes associated with bacteremia du to Acinetobacter species other than Acinetobacter baumannii. A review of laboratory and medical charts over a period of 18 months revealed 61 cases of bacteremia due to Acinetobacter species other than A. baumannii occurring in 59 patients. Six of these were considered not significant. Fifty cases represented catheter-related bacteremia, one case was associated with meningitis following brain surgery, and four cases could not be classified. Clinical courses wre usually benign: all but four patients were cured, but death was not related to Acinetobacter bacteremia in any case. Therapy included catheter removal alone (32.8%), appropriate antimicrobials alone (12.7%), or both (49.1%). Plasmid analysis showed distinct patterns in all strains isolated from different patients and did not reveal any epidemiological relationship among cases. Acinetobacter species other than A. baumannii are clinically significant organisms with limited pathogenic potential. They are almost exclusively involved in devise-related bacteremia. Clinical and epidemiological features of infections due to these organisms are clearly distinct from infections due to A. baumannii.
Similar articles
-
Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality.Medicine (Baltimore). 1995 Nov;74(6):340-9. doi: 10.1097/00005792-199511000-00004. Medicine (Baltimore). 1995. PMID: 7500897 Review.
-
Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organisms.J Infect Chemother. 2020 May;26(5):475-482. doi: 10.1016/j.jiac.2019.12.010. Epub 2020 Jan 7. J Infect Chemother. 2020. PMID: 31924521
-
The clinical characteristics of Acinetobacter bacteremia differ among genomospecies: A hospital-based retrospective comparative analysis of genotypically identified strains.J Microbiol Immunol Infect. 2019 Dec;52(6):966-972. doi: 10.1016/j.jmii.2019.09.007. Epub 2019 Oct 30. J Microbiol Immunol Infect. 2019. PMID: 31813733
-
Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.Southeast Asian J Trop Med Public Health. 2011 May;42(3):693-703. Southeast Asian J Trop Med Public Health. 2011. PMID: 21706949
-
Treatment of Acinetobacter infections.Expert Opin Pharmacother. 2010 Apr;11(5):779-88. doi: 10.1517/14656561003596350. Expert Opin Pharmacother. 2010. PMID: 20210684 Review.
Cited by
-
Acinetobacter baumannii: emergence of a successful pathogen.Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07. Clin Microbiol Rev. 2008. PMID: 18625687 Free PMC article. Review.
-
Antibody response to lipopolysaccharide in patients colonized or infected with an endemic strain of Acinetobacter genomic species 13 sensu Tjernberg and Ursing.Clin Diagn Lab Immunol. 2000 Mar;7(2):293-5. doi: 10.1128/CDLI.7.2.293-295.2000. Clin Diagn Lab Immunol. 2000. PMID: 10702507 Free PMC article.
-
Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods.J Clin Microbiol. 1997 Nov;35(11):2819-25. doi: 10.1128/jcm.35.11.2819-2825.1997. J Clin Microbiol. 1997. PMID: 9350741 Free PMC article.
-
Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes.Antimicrob Agents Chemother. 2006 Jan;50(1):388-90. doi: 10.1128/AAC.50.1.388-390.2006. Antimicrob Agents Chemother. 2006. PMID: 16377720 Free PMC article.
-
OXA-134, a naturally occurring carbapenem-hydrolyzing class D beta-lactamase from Acinetobacter lwoffii.Antimicrob Agents Chemother. 2010 Dec;54(12):5372-5. doi: 10.1128/AAC.00629-10. Epub 2010 Sep 13. Antimicrob Agents Chemother. 2010. PMID: 20837764 Free PMC article.